Considers legislation to include certain new antibiotics in Federal drug safety inspection regulations; to require exported drugs, food, cosmetics and devices to comply with domestic product safety standards; and to authorize FDA to charge importers for costs incurred in supervising relabeling and other procedures necessary to bring imported articles into compliance with domestic standards.